Literature DB >> 35169305

Recent Orange and Purple Book legislation suggests a need to bridge drug and biologic patent regimes.

Bryan S Walsh1, Jonathan J Darrow1,2, Aaron S Kesselheim3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35169305     DOI: 10.1038/s41587-021-01204-y

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.

Authors:  R A Lewis
Journal:  J Contemp Health Law Policy       Date:  1992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.